Biotech Startups

Base Therapeutics is a biopharmaceutical company working in the cell and gene therapy field, developing therapeutic products and research reagents and running clinical research projects for clients such as pharmaceutical companies, research institutes, universities, and hospitals. The page consists of job listings for operations, business development, sales, medical affairs, and R&D roles.

2 investors

Baz Biomedic develops a needle-free drug delivery system (NFID) for automatic, repeatable injection, aimed at dermatology, beauty, and medical applications. The company positions itself as an aesthetic medical technology provider serving the healthcare, industrial, and financial sectors.

2 investors

2 investors

Beaubrain develops AI-powered diagnostic and digital therapeutic solutions for dementia, focusing on early detection through biomarker prediction and brain health management. The company serves healthcare providers and patients at risk for Alzheimer's disease, leveraging partnerships with Samsung Medical Center for clinical validation and drug development.

2 investors

Believer Meats grows meat from animal cells in controlled environments without slaughtering animals. The company produces cultivated poultry and other meat products for consumers seeking alternatives to conventionally-farmed meat.

2 investors

Online gambling platform offering slots, live-dealer table games, crash-style games, and sports betting to players in Azerbaijan. Operated by Carlitta N.V. under a Curaçao license, with bonuses, multilingual interface, and mobile (Android APK / iOS) access.

2 investors

BerGenBio ASA was a company that merged with Oncoinvent ASA on 29 October 2025, with the combined entity renamed Oncoinvent. The current page serves only as an archive of historical documents related to BerGenBio prior to the merger.

2 investors

Berkeley Yeast develops genetically engineered yeast strains for the fermented beverages industry, offering improved flavor control, scalability, and consistency while reducing resource and energy consumption. The company produces yeast strains that replicate flavor compounds from fruits and plants or eliminate energy-intensive processing steps.

2 investors

Beta Bugs develops and distributes genetically selected Black Soldier Fly breeds for protein producers. The company supplies the biological genetics component of the insect farming supply chain to address protein production needs in the agri-food industry.

2 investors

BetaGlue develops solutions for the medical device and healthcare sector, supported by a board of directors with expertise in interventional radiology, nuclear medicine, and clinical operations.

2 investors

Betaliq is a clinical-stage pharmaceutical company developing topical eye-drop therapies for glaucoma using a licensed water-free drug delivery platform (EyeSol). Its lead candidate, BTQ1902, is a timolol suspension in development for elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

2 investors

BE Therapeutics is an early-stage biotech company developing stem cell-derived replacement tissue to repair damage to the brain and spinal cord caused by stroke, trauma, neurodegeneration, and aging. It engineers precursor brain tissue and biomaterials such as its "PiaGel" for pre-clinical and clinical applications in central nervous system repair.

2 investors

Better Juice develops an enzymatic technology that reduces natural sugars in fruit juices and other fruit-based foods and beverages by up to 80% while retaining flavor and nutrients, using natural enzymes in non-GMO microorganisms as a pass-through production step. It sells to food and beverage manufacturers seeking to create low-sugar, clean-label products.

2 investors

BH Therapeutics is a drug development company that uses structure-based rational drug design to identify structural limitations in existing therapies and design novel chemical scaffolds to address them. It develops a pipeline of medicines and conducts clinical trials.

2 investors

Bindbridge develops a molecular discovery platform that applies machine learning to agricultural challenges in plant biology and chemistry research.

2 investors

binx health develops FDA-cleared, CLIA-waived point-of-care diagnostic testing for chlamydia and gonorrhea in male and female patients, delivering central-lab-quality results in about thirty minutes so patients can test, get diagnosed, and receive treatment in one visit. The company operates in the diagnostics and sexual health space serving healthcare providers and their patients.

2 investors

BioAmp Diagnostics develops a chemistry-based rapid diagnostic pipeline (DETECT: Dual-Enzyme Trigger-Enabled Cascade Technology) that delivers infection results in minutes to guide antibiotic prescribing, initially targeting complicated urinary tract infections. The technology is intended to help physicians select the correct antibiotic and support efforts to combat antibiotic resistance.

2 investors

Bioceptive develops women's health medical devices, including a patented FDA-approved Cervical Suction Retractor that replaces the tenaculum for gynecological procedures and an IUD inserter, offering single-use disposable instruments aimed at reducing pain during transcervical procedures. It serves healthcare professionals in the U.S. and developing regions, and is based in New Orleans, Louisiana.

2 investors

Biocomposites develops and manufactures calcium-based and medical-grade polymer composite devices used in orthopaedic surgery, including products designed for use in the presence of infection. Founded via a management buyout of a ceramics company, it manufactures around one million units annually and sells to 100 countries.

2 investors

BioConnection is a Contract Development and Manufacturing Organization (CDMO) specializing in filling, finishing, and lyophilizing injectable biopharmaceutical products. The company operates from EMA and US-FDA-approved facilities in Oss, the Netherlands, serving innovative and generic pharmaceutical companies throughout the drug development lifecycle.

2 investors

BioCraft Pet Nutrition develops cell-cultured nutrition for cats and dogs, producing key nutrients for carnivorous pets without relying on conventionally farmed animals. The company focuses on pet food that reduces the environmental impact of animal-based ingredients.

2 investors

BioCsol develops engineered formulations combining active compounds with complementary mechanisms of action for agricultural use, delivering biodegradable solutions that protect soil health while preventing resistance.

2 investors

Develops edible, natural coatings and feed additives to extend the shelf life of perishable foods such as fish, seafood, meat, fruits and vegetables, and to improve poultry and aquaculture farm productivity. Products serve food suppliers and farms across the food supply chain, with additional packaging and cold-chain logistics solutions.

2 investors

BioEclipse Therapeutics is a clinical-stage oncology company developing immuno-oncology therapeutics using a proprietary platform that targets the tumor microenvironment through engineered immune cell therapies. The company's approach combines multiple mechanisms of action to eradicate cancer cells and generate durable immune responses against relapse and recurrence.

2 investors